Nov 23, 2020 | News
At the National Society of Genetic Counselors Annual Education Conference, CGI presented a poster on “Calculating and Communicating Error Estimates for Pathogenic Variant Classifications in Germline Sequence Tests.” The poster focused on CGI’s creation of a Positive...
Nov 23, 2020 | News
CGI presented its work on how pathogenic variant classifications are not always well-supported by evidence. Working together with genetic counselors from Rocky Mountain Cancer Centers and Texas Oncology, CGI collected de-identified patient reports and examined the...
Nov 13, 2020 | News
In October 2020, the Center for Genomic Interpretation (CGI) was awarded funding from the Utah Cancer Genomics Program for “Quality Matters: Recognizing and Assessing Differences in BRCA and Lynch Syndrome Genetic Tests Across Laboratories Most Used by Utah’s...
Nov 13, 2020 | News
Original Article: Quest Diagnostics Win in Wrongful Death Case Reveals Ongoing Challenges for Variant Classification Nov 12, 2020 NEW YORK – A federal district court judge in South Carolina granted summary judgement in favor of Quest Diagnostics last week,...
Nov 12, 2020 | News
Dr. Julie Eggington, Co-founder and CGI CEO, was asked by the press to comment on the outcomes of the Williams v Quest/Athena variant classification lawsuit: “Experts acknowledged…that variant classification remains a growing source of lab liability that the genetic...
Recent Comments